Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
Key Details
- 1scSurvival is a machine learning model designed for single-cell resolution analysis in cancer assessment.
- 2Developed with NIH funding by Oregon Health & Science University researchers.
- 3Tested on data from over 150 cancer patients, the tool linked specific tumor and immune cell populations to varying risk and survival outcomes.
- 4The model outperformed traditional methods in predicting outcomes in melanoma and liver cancer.
- 5Research appeared in the journal Cancer Discovery on April 21, 2026.
Why It Matters
Single-cell analytics and AI are at the cutting edge of precision oncology, offering deeper insight into tumor heterogeneity and treatment response. These advances may significantly enhance radiology's role in prognostication and personalized care, especially as multi-modal data integration becomes more common.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.